Regulator approves first injectable treatment for prevention of HIV Cabotegravir has been approved as pre-exposure prophylaxis in the UK in both tablet and injectable form.…
Hepatitis C ‘micro-eliminated’ at UK’s largest prison The test-and-treat programme is part of a plan from Welsh government to micro-eliminate hepatitis C in the community and in all Welsh prisons.…
PJ view: Private COVID-19 vaccines should be welcomed with caution As pharmacies prepare to offer private COVID-19 vaccinations, cost considerations must be made to ensure this does not become a step towards wider health inequality.…
Pilots to provide PrEP via pharmacies only ‘possible future opportunities’, report warns A report from the HIV Action Plan Implementation Steering Group said it was “concerning that the current proposal for PrEP pilots is marked as ‘possible future opportunities’”.…
Community pharmacy expected to play ‘greater role’ in delivering vaccines under new strategy NHS England’s vaccination strategy delegates responsibility for commissioning vaccination services from NHS England to integrated care boards by April 2025.…
Almost a third of community pharmacies providing COVID-19 jabs during autumn booster season More than 3,500 pharmacies in England are registered to provide COVID-19 vaccinations for the 2023 autumn booster programme.…
Test yourself: the 2023 CPD and Learning quiz Assess your knowledge on topics ranging from infectious diseases, to professional skills, to cardiology, in our end-of-year CPD and learning quiz.…
European regulator’s committee recommends new safety measures for medicines containing pseudoephedrine The European Medicines Agency's risk assessment committee has recommended that medicines containing pseudoephedrine should not be used in patients with severe or uncontrolled high blood pressure, or people with severe acute or chronic kidney disease or failure.…
PrEP highly effective in cutting HIV transmission but better access needed, study finds Results of the 'PrEP Impact' trial show that PrEP reduced the chances of someone getting HIV by around 87%.…
Community pharmacy staff asked for views on provision of PrEP as part of NIHR research project The University of Bristol is conducting research on the barriers community pharmacies must overcome if they are to provide HIV pre-exposure prophylaxis.…
